Page last updated: 2024-08-22

ruthenium and Animal Mammary Carcinoma

ruthenium has been researched along with Animal Mammary Carcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergamo, A; Dyson, PJ; Riedel, T; Sava, G1
Cocchietto, M; Sava, G; Sorc, A; Zorzet, S1
Alessio, E; Bergamo, A; Casarsa, C; Cocchietto, M; Haasnoot, JG; Sava, G; Velders, AH; Zangrando, E; Zorzet, S1
Casarsa, C; Mischis, MT; Sava, G1

Other Studies

4 other study(ies) available for ruthenium and Animal Mammary Carcinoma

ArticleYear
Preclinical combination therapy of the investigational drug NAMI-A(+) with doxorubicin for mammary cancer.
    Investigational new drugs, 2015, Volume: 33, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Dimethyl Sulfoxide; Doxorubicin; Humans; Kidney; Liver; Lung; Lung Neoplasms; Mammary Neoplasms, Animal; MCF-7 Cells; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Ruthenium Compounds

2015
Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration.
    Investigational new drugs, 2003, Volume: 21, Issue:1

    Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dimethyl Sulfoxide; Disease Models, Animal; Female; Injections, Intraperitoneal; Kidney; Liver; Lung; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Species Specificity

2003
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]p
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Hydrolysis; Kidney; Liver; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Matrix Metalloproteinase 9; Mice; Molecular Structure; Neoplasm Invasiveness; Neoplasm Metastasis; Organometallic Compounds; Ruthenium; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Tissue Distribution

2004
TGFbeta1 regulation and collagen-release-independent connective tissue re-modelling by the ruthenium complex NAMI-A in solid tumours.
    Journal of inorganic biochemistry, 2004, Volume: 98, Issue:10

    Topics: Animals; Cell Line, Tumor; Coculture Techniques; Collagen; Connective Tissue; Dimethyl Sulfoxide; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Mice; Mice, Inbred CBA; Molecular Structure; NIH 3T3 Cells; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Transforming Growth Factor beta; Transforming Growth Factor beta1

2004